MOTS-c, SS-31, NAD+, and mitochondria-targeting peptides for energy research.
🔥 Popular
NEW BATCH
COA ✓
Mitochondrial peptides target the powerhouse of the cell directly - protecting the inner membrane, restoring NAD+ levels, and activating metabolic pathways that decline with age. SS-31 (Elamipretide) is the most advanced mitochondria-targeting peptide in clinical development, while NAD+ supplementation addresses the coenzyme depletion that underlies age-related metabolic decline.
| Compound | Target | Mechanism | Dosages | Clinical Status |
|---|---|---|---|---|
| SS-31 (Elamipretide) | Cardiolipin | IMM stabilization, ETC optimization | 10/27/47mg | Phase III (Barth syndrome) |
| NAD+ | NAD+ pool | Direct NAD+ replenishment | 500mg | Widely studied nutraceutical |
| PNC-27 | HDM2 membrane | p53-derived membranolytic peptide | 30mg | Preclinical research |
SS-31 is a cell-permeable tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that concentrates 1000-fold in mitochondria. It binds cardiolipin at the inner mitochondrial membrane, preventing cytochrome c peroxidase activity and optimizing electron transport chain coupling, reducing ROS production at the source.
NAD+ is required for sirtuin (SIRT1-7) activity, which regulates mitochondrial biogenesis, DNA repair, and metabolic homeostasis. Direct IV NAD+ supplementation bypasses the rate-limiting steps of oral precursors (NMN, NR), providing immediate cofactor availability for mitochondrial longevity pathways.
SS-31 and PNC-27 require bacteriostatic water for reconstitution. NAD+ is supplied as a pH-buffered solution ready for research use. Use the reconstitution calculator and dosage calculator for lyophilized products.